EE200200620A - IL-18 inhibiitorite kasutamine ravimi valmistamiseks, mis on ette nähtud ateroskleroosi ravimiseks ja/või ennetamiseks - Google Patents

IL-18 inhibiitorite kasutamine ravimi valmistamiseks, mis on ette nähtud ateroskleroosi ravimiseks ja/või ennetamiseks

Info

Publication number
EE200200620A
EE200200620A EEP200200620A EEP200200620A EE200200620A EE 200200620 A EE200200620 A EE 200200620A EE P200200620 A EEP200200620 A EE P200200620A EE P200200620 A EEP200200620 A EE P200200620A EE 200200620 A EE200200620 A EE 200200620A
Authority
EE
Estonia
Prior art keywords
atherosclerosis
medicament
inhibitors
prevention
preparation
Prior art date
Application number
EEP200200620A
Other languages
English (en)
Inventor
Chvatchko Yolande
Tedgui Alain
Mallat Ziad
Original Assignee
Applied Research Systems Ars Holding N.V.
Inserm - Institut National De La Sante Et De La Recherche Medicale
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Applied Research Systems Ars Holding N.V., Inserm - Institut National De La Sante Et De La Recherche Medicale filed Critical Applied Research Systems Ars Holding N.V.
Publication of EE200200620A publication Critical patent/EE200200620A/et
Publication of EE05056B1 publication Critical patent/EE05056B1/et

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2866—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for cytokines, lymphokines, interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/244—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cardiology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Vascular Medicine (AREA)
  • Obesity (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
EEP200200620A 2000-05-05 2001-04-30 IL-18 inhibiitorite kasutamine ravimi valmistamiseks, mis on ette n„htud ateroskleroosi ravimiseks ja/v?i ennetamiseks EE05056B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00109606 2000-05-05
PCT/EP2001/004843 WO2001085201A2 (en) 2000-05-05 2001-04-30 Use of il-18 inhibitors for the treatment and/or prevention of atherosclerosis

Publications (2)

Publication Number Publication Date
EE200200620A true EE200200620A (et) 2004-06-15
EE05056B1 EE05056B1 (et) 2008-08-15

Family

ID=8168631

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200200620A EE05056B1 (et) 2000-05-05 2001-04-30 IL-18 inhibiitorite kasutamine ravimi valmistamiseks, mis on ette n„htud ateroskleroosi ravimiseks ja/v?i ennetamiseks

Country Status (33)

Country Link
US (1) US20040076628A1 (et)
EP (1) EP1278540B1 (et)
JP (1) JP5122053B2 (et)
KR (2) KR100798545B1 (et)
CN (2) CN1841066B (et)
AR (1) AR035640A1 (et)
AT (1) ATE395075T1 (et)
AU (2) AU6739001A (et)
BG (1) BG65881B1 (et)
BR (1) BRPI0110506B8 (et)
CA (1) CA2407895C (et)
CY (1) CY1110385T1 (et)
CZ (1) CZ300792B6 (et)
DE (1) DE60134009D1 (et)
DK (1) DK1278540T3 (et)
EA (2) EA005410B1 (et)
EE (1) EE05056B1 (et)
ES (1) ES2305082T3 (et)
HK (2) HK1055681A1 (et)
HR (1) HRP20020828A2 (et)
HU (1) HU229375B1 (et)
IL (2) IL152567A0 (et)
ME (1) ME00554B (et)
MX (1) MXPA02010895A (et)
NO (1) NO329821B1 (et)
PL (1) PL209371B1 (et)
PT (1) PT1278540E (et)
RS (1) RS50926B (et)
SI (1) SI1278540T1 (et)
SK (1) SK287761B6 (et)
UA (2) UA87658C2 (et)
WO (1) WO2001085201A2 (et)
ZA (1) ZA200208228B (et)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001058956A2 (en) * 2000-02-10 2001-08-16 Abbott Laboratories Antibodies that bind human interleukin-18 and methods of making and using
CA2435466C (en) * 2001-01-29 2012-04-03 Applied Research Systems Ars Holding N.V. Use of il-18 inhibitors for the treatment and/or prevention of heart disease
CN1305529C (zh) * 2001-05-25 2007-03-21 阿雷斯贸易股份有限公司 Il－18抑制剂在治疗或预防中枢神经***损伤中的应用
US6797727B2 (en) 2001-07-16 2004-09-28 Transition Therapeutics Inc. Use of rhein or diacerhein compounds for the treatment or prevention of vascular diseases
US8729124B2 (en) 2002-03-05 2014-05-20 Pronova Biopharma Norge As Use of EPA and DHA in secondary prevention
GB0210212D0 (en) * 2002-05-03 2002-06-12 Univ Southampton Effects of dietary N-3 and N-6 pufa intake on atheromatous plaque stability
ME00548B (me) * 2002-03-22 2011-10-10 Serono Lab Korišćenje inhibitora il-18 za liječenje i/ili prevenciju perifernih vaskularnih bolesti
ATE399872T1 (de) * 2003-03-11 2008-07-15 Serono Lab Expressionvektoren, die den promotor des ie2-gens des maus cytomegalovirus enthalten
SI1622939T1 (sl) 2003-05-13 2012-06-29 Merck Serono Sa Akrivne variante il-18 vezavnega proteina in medicinske uporabe le-tega
US7968684B2 (en) 2003-11-12 2011-06-28 Abbott Laboratories IL-18 binding proteins
PT1755642E (pt) * 2004-04-15 2010-04-20 Athera Biotechnologies Ab Anexina v para prevenção de aterotrombose e da ruptura de placas
CN101219208B (zh) * 2005-01-04 2010-08-11 健能隆医药技术（上海）有限公司 白介素-22的医药用途
AU2006254103B2 (en) 2005-06-03 2012-09-06 Ares Trading S.A. Production of recombinant IL-18 binding protein
RS52273B (en) 2005-06-10 2012-10-31 Ares Trading S.A. PROCESS FOR PURIFICATION OF IL-18 BINDING PROTEIN
RU2013110874A (ru) 2010-08-25 2014-09-27 Ф.Хоффманн-Ля Рош Аг Антитела против il-18r1 и их применения
JOP20200308A1 (ar) 2012-09-07 2017-06-16 Novartis Ag جزيئات إرتباط il-18
MD707Z (ro) * 2013-01-18 2014-07-31 Институт Зоологии Академии Наук Молдовы Metodă de identificare a secvenţelor polimorfe 4a/4b ale genei sintetazei endoteliale a oxidului nitric
HUE055608T2 (hu) 2013-09-05 2021-12-28 Ab2 Bio Sa IL-18-kötõ fehérje (IL-18BP) gyulladásos betegségekben
MX2017010919A (es) 2015-03-05 2017-12-07 Ab2 Bio Sa Proteina de union il-18 (il-18bp) y anticuerpos en enfermedades inflamatorias.
CN110273591B (zh) 2019-08-13 2023-12-12 上海杉脉电子科技发展有限公司 一种单动力微型智能锁
TW202233675A (zh) 2020-10-29 2022-09-01 瑞士商諾華公司 Ｉｌ－１８拮抗劑用於治療和／或預防異位性皮炎或相關病症之用途
CN112972655A (zh) * 2021-04-16 2021-06-18 武汉大学 白细胞介素12在制备预防、缓解和/或治疗主动脉瘤药物中的应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5985863A (en) * 1996-09-12 1999-11-16 Vertex Pharmaceuticals, Inc. Compositions and methods for decreasing IGIF and IFN-γ production by administering an ICE inhibitor
US5877197A (en) * 1996-12-16 1999-03-02 Karanewsky; Donald S. C-terminal modified (N-substituted)-2-indolyl dipeptides as inhibitors of the ICE/ced-3 family of cysteine proteases
IL121860A0 (en) * 1997-08-14 1998-02-22 Yeda Res & Dev Interleukin-18 binding proteins their preparation and use
CA2276216A1 (en) * 1998-06-24 1999-12-24 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo An artificial peptide capable of neutralizing the biological activity of interleukin-18
EP0987552A3 (en) * 1998-08-31 2000-06-07 Pfizer Products Inc. Diarylsulfonylurea binding proteins
KR100537558B1 (ko) * 1998-09-01 2005-12-19 가부시끼가이샤 하야시바라 세이부쓰 가가꾸 겐꾸조 인터류킨-18 결합 단백질

Also Published As

Publication number Publication date
PL365697A1 (en) 2005-01-10
HUP0301991A3 (en) 2006-11-28
AR035640A1 (es) 2004-06-23
EP1278540B1 (en) 2008-05-14
BG107218A (bg) 2003-06-30
DE60134009D1 (de) 2008-06-26
SK287761B6 (en) 2011-09-05
MEP64008A (en) 2011-12-20
HU229375B1 (en) 2013-11-28
MXPA02010895A (es) 2003-03-27
BG65881B1 (bg) 2010-04-30
HRP20020828A2 (en) 2004-12-31
NO20025307L (no) 2002-12-18
AU2001267390B2 (en) 2005-09-22
UA87658C2 (uk) 2009-08-10
AU6739001A (en) 2001-11-20
BR0110506A (pt) 2003-04-01
EA005410B1 (ru) 2005-02-24
ME00554B (me) 2012-03-20
SK15562002A3 (sk) 2003-05-02
RS50926B (sr) 2010-08-31
CN1841066A (zh) 2006-10-04
KR100798545B1 (ko) 2008-01-28
EA007014B1 (ru) 2006-06-30
WO2001085201A2 (en) 2001-11-15
PT1278540E (pt) 2008-07-03
CZ300792B6 (cs) 2009-08-12
CY1110385T1 (el) 2015-04-29
KR20070073989A (ko) 2007-07-10
SI1278540T1 (sl) 2008-10-31
ATE395075T1 (de) 2008-05-15
JP2003532685A (ja) 2003-11-05
DK1278540T3 (da) 2008-07-21
WO2001085201A3 (en) 2002-05-10
NO329821B1 (no) 2010-12-27
ES2305082T3 (es) 2008-11-01
CZ20023644A3 (cs) 2003-03-12
UA78492C2 (en) 2007-04-10
YU82602A (sh) 2006-01-16
IL152567A0 (en) 2003-05-29
NO20025307D0 (no) 2002-11-05
CN1841066B (zh) 2012-08-29
BRPI0110506B1 (pt) 2015-05-19
ZA200208228B (en) 2005-07-27
CA2407895C (en) 2012-12-18
HK1055681A1 (en) 2004-01-21
CN1434722A (zh) 2003-08-06
KR20030016254A (ko) 2003-02-26
EA200201175A1 (ru) 2003-04-24
PL209371B1 (pl) 2011-08-31
JP5122053B2 (ja) 2013-01-16
EP1278540A2 (en) 2003-01-29
HUP0301991A2 (hu) 2003-09-29
US20040076628A1 (en) 2004-04-22
IL152567A (en) 2010-12-30
CN1250286C (zh) 2006-04-12
BRPI0110506B8 (pt) 2021-05-25
HK1094909A1 (en) 2007-04-13
EE05056B1 (et) 2008-08-15
EA200401183A1 (ru) 2004-12-30
CA2407895A1 (en) 2001-11-15

Similar Documents

Publication Publication Date Title
EE200200620A (et) IL-18 inhibiitorite kasutamine ravimi valmistamiseks, mis on ette nähtud ateroskleroosi ravimiseks ja/või ennetamiseks
ATE258928T1 (de) Respiratorisches syncytialvirus replikation inhibitoren
IL196301A0 (en) Medicament for the treatment of hapatitis c
ATE259796T1 (de) Respiratorisches syncytialvirus replikation inhibitoren
ATE276244T1 (de) Replikationsinhibitoren des respiratorischen synzytialvirus
NO20031672D0 (no) Aza- og polyaza-naftalenylkarboksamider for anvendelse som HIV-integraseinhibitorer
PT1313489E (pt) Composicoes farmaceuticas para o tratamento de mucosite, estomatite e sindroma de behcet
EE200300212A (et) Ravimite kombinatsioonid (näiteks kloorpromasiin ja pentamidiin) neoplastiliste haiguste raviks
DK1335678T3 (da) Oralt behandlingssystem
MXPA03005731A (es) Articulo absorbente que tiene tratamientos medicinales liberables.
EP1367060A4 (en) GLUCOPYRANOSYLOXYBENZYLBENZENE DERIVATIVES AND THEIR MEDICAL USE
EP1364957A4 (en) GLYCOPYRANOSYLOXYPYRAZOLE DERIVATIVES AND THEIR MEDICAL USE
EP1364958A4 (en) GLYCOPYRANOSYLOXYPYRAZOLE DERIVATIVES AND MEDICINAL USE THEREOF
EE200200550A (et) Karbamaatsed kaspaasi inhibiitorid ja nende kasutamine
EE200200214A (et) Dipüridamooli või mopidamooli kasutamine sellise ravimi valmistamiseks, mis on ette nähtud fibriinsõltuvate mikrotsirkulatsiooni häirete ennetamiseksja raviks
EE05534B1 (et) IL-18 inhibiitorite kasutamine ravimi valmistamiseks kardiomopaatia raviks ja/v?i ennetamiseks
GB0105613D0 (en) Pharmaceutically effective compounds and their use
HK1051692A1 (en) Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain.
EE05174B1 (et) Kemokiini mutandi kasutamine farmatseutilise kompositsiooni valmistamiseks, mis on ette n„htud hulgiskleroosi ja teiste meliinikaotusega seotud haiguste raviks
IL151765A0 (en) Hydroxyphenyl-piperazinyl-methyl-benzamide derivatives for the treatment of pain
NO20032006L (no) Anvendelse av melagatran for fremstilling av et medikament for behandling av ischemiske lidelser
EE200200698A (et) Ravimid neurodegeneratiivsete haiguste ennetamiseks ja raviks
HUP0300717A3 (en) Drug combination for the treatment of headache comprising mirtazapine and paracetamol or a non-steroidal anti-inflammatory drug
HK1054873A1 (en) Pharmaceutical composition based on cocaethylene and use thereof for treating psychoactive substancedependence
PT1140090E (pt) Utilizacao de fanquinona para o tratamento ou prevencao da perda de memoria

Legal Events

Date Code Title Description
GB1A Change in the ownership or in the address of the owner
KB4A Valid patent at the end of a year

Effective date: 20081231

KB4A Valid patent at the end of a year

Effective date: 20101231

HC1A Change of owner name